Disclosure of Unlabeled/Investigational Uses

Unlabeled Uses/Investigational Uses/Not Yet Approved Therapies

The learners are advised that some sections in this continuing nursing education activity may contain references to devices and/or protocols or clinical strategies that are unlabeled, investigational, or unapproved by the FDA. Healthcare professionals should note that the use of information presented that is outside of current approved labeling is considered experimental and are advised to consult current prescribing information. All faculty members have agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in their presentation.

Lauren J. Isley, MS, LCGC

Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Maria M. Jackson, RN, MA

Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Carol B. Lesser, MSN, NP-C

Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Daniel B. Shapiro, MD

Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Kaylen M. Silverberg, MD

Has agreed to disclose any unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies referenced in his presentation